Samsung Targets U.S. Drug Market With Remicade Knockoff

Samsung Group said its near-replica of Johnson & Johnson’s blockbuster arthritis drug Remicade has been accepted for review by the U.S. Food and Drug Administration.

from WSJ.com: US Business http://ift.tt/1VfZN9E
via IFTTT